4'-Epi-6'-hydroxyadriamycin and method of use

Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated via claimed linking group – bond – chelating agent,...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

536 4, 536 17, 536 18, A61K 3171

Patent

active

040256235

ABSTRACT:
The novel glycoside antibiotic: 4'-epi-6'-hydroxydaunomycin is prepared by condensing daunomycin with a novel protected, reactive derivative, which is 1,2,3-trideoxy-4,6-di-O-(p-nitrobenzoyl)-3-trifluoroacetamido-L-arabino -hex-1-enepyranose and thereafter removing the protecting groups. A further novel glycoside antibiotic: 4'-epi-6'-hydroxyadriamycin is prepared by reacting 4'-epi-6'-hydroxydaunomycin with bromine to form an intermediate bromo derivative which is then mildly hydrolyzed to form 4'-epi-6'-hydroxyadriamycin. These novel glycoside antibiotics, while not as effective as the parent compounds daunomycin and adriamycin in the treatment of tumors, are considerably less toxic than the parent compounds.

REFERENCES:
patent: 3784541 (1974-01-01), Culbertson et al.
patent: 3803124 (1974-04-01), Arcamone et al.
Pigman "The Carbohydrates," Academic Press Inc., New York, N.Y., pp. 208-213.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

4'-Epi-6'-hydroxyadriamycin and method of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4'-Epi-6'-hydroxyadriamycin and method of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4'-Epi-6'-hydroxyadriamycin and method of use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-537604

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.